ClinicalTrials.gg
Drug

Rubitecan clinical trials

studies test it
16
open now
0
in phase 3
1
first study started
1999

How each study uses rubitecan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

rubitecan
14

Development codes

PEG-1000
1

Studies by the year they started

15 studies that test it; most in 2000 (7)

Studies that test rubitecan, by start year
YearStudies
19995
20007
20011
20031
20051

Who runs them

Industry 8 · Other 8

Astex Pharmaceuticals, Inc. (8) · European Organisation for Research and Treatment of Cancer - EORTC (4) · Alliance for Clinical Trials in Oncology (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · University of New Mexico (1) · Gynecologic Oncology Group (1)

Often tested with

Tested in the same studies.

Etoposide (1)

Studies

Open first, then newest update. How each study uses rubitecan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 16

Codes

What other systems call rubitecan · ClinicalTrials.gg INT003711

  • MeSH (NLM) C079905rubitecanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) H19C446XXBRUBITECANConfirmed FDA, NLM, Wikidata
  • Wikidata Q510113rubitecanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1485RubitecanOne source FDA
  • DrugBank DB06159One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.